Is DaBomb Protein Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, DaBomb Protein Biotech pays dividends. Last time was Friday 30th of August 2024 where the investors holding the stock on Tuesday 30th of July 2024 were paid TWD0.50926 per share. Over the last 8 times between 2016 and 2024, DaBomb Protein Biotech has paid TWD4.709 with an average of TWD0.59 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for DaBomb Protein Biotech 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD20.59, you would have made a loss of TWD-1.740 per share or -8.45%
Yes, the average daily trading liquidity for DaBomb Protein Biotech is TWD234 933 thousand. You should therefore be able to get in and out of your positions relatively fast.
DaBomb Protein Biotech has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.12, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 2.02%, which is challenging.
We have calculated the inflation risk for DaBomb Protein Biotech to be low [0.5 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.